Organisation paid for research Program year 2024 Source: CMS Open Payments

Henry Ford Hlth Syst

Neither a doctor nor a teaching hospital

Research payments

$4,987,065

117 payments

Through program year 2024, Henry Ford Hlth Syst is reported as receiving $4,987,065 in research payments, across 117 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2024	Research	$258,123	27
2023	Research	$1,425,612	42
2022	Research	$3,215,697	32
2021	Research	$48,369	3
2019	Research	$39,264	13

Breakdown

Who paid Research payments · program years 2019–2024

Janssen Research & Development, LLC $4,987,065 117 payments

Studies the money was for Research payments · program years 2019–2024

A Study of Ad26.COV2.S for the Prevention of SARSCoV2 Mediated COVID19 in Adult Participants $3,602,420 22 payments
A Study of Ad26.COV2.S for the Prevention of SARSCoV2mediated COVID19 in Adults $613,761 17 payments
Noprodvir0001 $347,474 12 payments
Cnto1959pso3018 $151,246 17 payments
A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years $120,262 22 payments
A Multi Center Randomized Double Blind Placebo Controlled Phase III Study of ARN509 in Men With Non Metastatic M0 Castration Resistant Prostate Cancer $48,144 2 payments
Cnto1959pso3017 $44,869 8 payments
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Study of ARN-509 in Men With Non-Metastatic (M0) Castration-Resistant Prostate Cancer $23,368 8 payments
Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia A Multi Center Randomized Double blind Placebo controlled Study $17,900 1 payment
A Phase 3 study comparing daratumumab . Lenalidomide and dexamethasone (DRd) versus lenalidomide and Dexamethasone (Rd) in patients with newly diagnosed multiple myeloma who are not eligible for high dose chemotherapy and autologous stem cell transplant $15,884 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.